Pharmacist-Led lessons may cut infection risk in chemo patients

NCT ID NCT07690956

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This trial tests whether a pharmacist-led educational program helps cancer patients on high-risk chemotherapy better understand and follow neutropenic precautions—steps to prevent serious infections when white blood cell counts are low. About 300 adults with various cancers will either receive standard care or additional education including written materials, a counseling session, and a video. Researchers will measure changes in knowledge, adherence to precautions, and infection rates over 2-6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Pharmacist-Led Neutropenic Education Package (P-NEP)
What this could lead to
If effective, this educational approach could reduce infection rates and improve safety for cancer patients undergoing chemotherapy.
What could go wrong
This is a single-center study with 300 participants, so results may not apply broadly. The intervention relies on self-reported adherence, which can be biased.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer Febrile Neutropenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AlBashir Hospital

    Amman, 11151, Jordan

  • King Abdullah University Hospital (KAUH)

    Irbid, 22110, Jordan

More trials for these conditions

Other studies related to the condition(s) this trial covers.